Editorial
doi: 10.1016/j.jacc.2017.04.045.
When Less Is Not More
Affiliations
- PMID: 28595693
- DOI: 10.1016/j.jacc.2017.04.045
Item in Clipboard
Editorial
When Less Is Not More
J Am Coll Cardiol.
.
Free article
No abstract available
Keywords: atrial fibrillation; bleeding; non–vitamin K antagonist oral anticoagulant; renal function; stroke; underdosing.
Comment on
-
Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.J Am Coll Cardiol. 2017 Jun 13;69(23):2779-2790. doi: 10.1016/j.jacc.2017.03.600. J Am Coll Cardiol. 2017. PMID: 28595692
Similar articles
-
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29. Int J Stroke. 2016. PMID: 26927811
-
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.Am J Med. 2015 Sep;128(9):1007-14.e2. doi: 10.1016/j.amjmed.2015.03.034. Epub 2015 Apr 22. Am J Med. 2015. PMID: 25910790 Clinical Trial.
-
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510. BMJ. 2017. PMID: 28188243 Free PMC article.
-
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.Clin Interv Aging. 2015 Sep 3;10:1431-44. doi: 10.2147/CIA.S80641. eCollection 2015. Clin Interv Aging. 2015. PMID: 26366064 Free PMC article. Review.
-
Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.J Am Heart Assoc. 2017 Jul 18;6(7):e005835. doi: 10.1161/JAHA.117.005835. J Am Heart Assoc. 2017. PMID: 28720644 Free PMC article. Review.
Cited by
-
Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis.Open Heart. 2023 May;10(1):e002197. doi: 10.1136/openhrt-2022-002197. Open Heart. 2023. PMID: 37169490 Free PMC article.
-
Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.Br J Clin Pharmacol. 2023 Feb;89(2):751-761. doi: 10.1111/bcp.15534. Epub 2022 Oct 3. Br J Clin Pharmacol. 2023. PMID: 36102068 Free PMC article.
-
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation.J Arrhythm. 2021 Nov 13;37(6):1389-1426. doi: 10.1002/joa3.12652. eCollection 2021 Dec. J Arrhythm. 2021. PMID: 34887945 Free PMC article.
-
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13. Thromb Haemost. 2022. PMID: 34773920 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
